Praxis Precision Medicines (NASDAQ: PRAX) is owned by 91.08% institutional shareholders, 9.58% Praxis Precision Medicines insiders, and 0.00% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 3.81% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $8.17M.
If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.